The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Open accessAbstract
Study Objective. To estimate the relative risk of hip fracture associated with proton pump inhibitor (PPI) use in a population without major risk factors. Design. A two‐phase, matched, nested case‐control study. Data Source. United Kingdom General Practice Research Database (GPRD). Patients. Phase 1 identified 4414 case patients (aged 50–79 yrs) with an incident hip fracture between 1995 and 2005 who had at least 2 years of recorded history in the GPRD; each case was matched by age, sex, and index date (date of first‐time hip fracture for cases, same date for matched controls) to up to 10 controls who did not have hip fracture. Phase 2 included the 1098 case patients identified as having no major medical risk factors for hip fracture (as assessed in phase 1) and a new set of 10,923 controls without major risk factors for hip fracture matched by sex, age, index date, and duration of history in the GPRD. Measurements and Main Results. In phase 1, we identified major medical risk factors for hip fracture. In phase 2, we restricted the study to case patients with none of these risk factors and matched them to new controls, who also had none of the risk factors. Data on use of PPIs were collected and compared between the groups. The relative risk (RR) for hip fracture among patients who received any PPI prescription was 0.9 (95% confidence interval 0.7‐1.1) compared with those with no PPI prescription. We found no evidence of an increased risk of hip fracture with increased PPI use. The RR estimates were similar in both sexes and in all age subgroups. No specific PPI was associated with an increased risk of hip fracture. Conclusion. Use of PPIs does not increase the risk of hip fracture in patients without major risk factors. The difference in results between our study and that of another, which indicated that PPI use increases the risk of hip fracture, may be due to residual confounding or effect modification in the latter study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CASE-CONTROL STUDIES IN THE EVALUATION OF DRUG-INDUCED ILLNESS
JICK, H., & VESSEY, M. P. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112502 · Cited by 123
Self-citation
Cited by
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., DiLorenzo, C., Gottrand, F., Gupta, S., Langendam, M., Staiano, A., Thapar, N., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001889 · Cited by 1,557
Vandenplas, Y., Rudolph, C. D., Committee Members:, Di Lorenzo, C., Hassall, E., Liptak, G., Mazur, L., Sondheimer, J., Staiano, A., Thomson, M., et al. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181b7f563 · Cited by 742
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
Gray, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.94 · Cited by 329
Metadata
- Authors
- Kaye, J. A., & Jick, H.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2008-08
- Volume
- 28
- Issue
- 8
- Pages
- 951-959
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2014906602
- Cited by
- 182
- References
- 1
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors. https://app.cochat.ai/papers/10.1592/phco.28.8.951
- The paper
- Kaye, J. A., & Jick, H. (2008). Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.28.8.951
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.